Uranium is shifting back into favour with investors as spot prices reflect positive signals for demand from the nuclear power ...

Several ASX-listed companies have partnered with Cell Therapies, based at Peter Mac to manufacture CAR-T and other cell ...

America's 90-day trade-war truce with China has jolted markets awake and reset the narrative for investors, traders and ...

In a world first, Compumedics has shown that its MEG brain scanning tool can image adults and children at the same time.

Amid declining reserves and surging demand, Andromeda is turning up the heat on kaolin with its development-ready Great White asset.

Wall Street’s flying but the ASX skids this morning. Life360 rockets again, while stocks like Macquarie and Aristocrat stumble.

A soaring gold price is powering a bid to revive the Bullabulling mine near Coolgardie, as new developers line up to join a ...

The ASX has gained more than 0.7pc in early trade as global markets celebrate the result of US-China trade talks, slashing ...

Investors with a short position in wound care house Polynovo face a 'short squeeze' after type 1 diabetes trial results.

West African gold M&A is blowing up, with Côte d'Ivoire at the centre of a strategic game that could lift more ASX gold plays ...

Small-cap explorer Codrus Minerals is about to embark on its first drilling campaign at its US gold project dubbed Bull Run.

Slashed tariffs on US-China trade have set the bulls running – the ASX is no different today, climbing 0.37pc on strength in Tech and Energy.